Delcath Systems Stock Price and Value Analysis

Should you buy Delcath Systems stock? (Other OTC:DCTH). Let's see how it does in our automated value investing analysis system.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Delcath Systems to reach your target.

Target type

DCTH Free Cash Flow Trend

Free Cash Flow trendline for DCTH
Free Cash Flow trendline for Delcath Systems

Hmm, we can't give any reliable projection for Delcath Systems's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

AdvantagesDisadvantagesNeutral
  • This company has stable growth.
  • This company is solid.
  • This company is not making money.
  • This stock looks overpriced.
  • This company pays no dividend.

Inside the DCTH Numbers

DCTH Price
(Delcath Systems stock price per share)
$16.15
[?] PE Ratio versus Sector 100% lower than other Healthcare stocks
[?] PE Ratio versus Industry 0% lower than other Drug Delivery stocks
[?] Cash Yield -17.52%
[?] Free Cash Flow Jitter 18%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 390,020 shares shorted. With 3,448,646 shares available for purchase and an average trading volume over the past 10 trading days of 92,328, it would take at least 4.224 days for all of the short holders to cover their shorts.

Continue Learning: Value Investing Guides

Is Delcath Systems Stock on Sale?

Based on our analysis, we believe that you should not buy Delcath Systems right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Advertisement supports free stock analysis content.

Should You Buy DCTH Stock?

Does Delcath Systems have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: DCTH

This example shows how we apply the Trendshare checklist to DCTH: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 16.15
    • Market cap: $94M
    • EPS: -2.912
  2. Step 2 — Valuation checks

    • P/E:
    • FCF yield: -17.5%
    • Date checked: Dec 26, 2025
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.
Illustrative sparkline of recent price-like movements (not an actual price series). The blue line shows a simplified trend; the gray baseline is a notional recent level. This graphic is a visual aid only — use the numeric values in the steps above for decisions.